Abstract: Individualized porous particles having a volume-average diameter of less than or equal to 10 ?m and a specific surface area of greater than or equal to 1 m2/g, and that include at least one cosmetically or pharmaceutically active compound present at least inside the particles.

Abstract: Individualized porous particles having a volume-average diameter of less than or equal to 10 ?m and a specific surface area of greater than or equal to 1 m2/g, and that include at least one cosmetically or pharmaceutically active compound present at least inside the particles.

Abstract: Individualized porous particles have a volume-average diameter of less than or equal to 10 ?m and a specific surface area of greater than or equal to 1 m2/g, and include at least one cosmetically or pharmaceutically active compound present at least inside the particles.

Abstract: The invention relates to a process for the fake-proof marking of a product, by introducing at least one non-radioactive stable isotope of at least one atomic element, such that the content of the isotope in the product is higher than its natural content, the isotope being chosen from natural isotopes that have a natural isotopic content of less than 1.2%, and better still less than 1%.

Abstract: The present disclosure relates to the use of a liquid detergent composition, with a viscosity ranging from 1 mPa/s to 100 mPa/s, comprising at least 5% of at least one detergent surfactant, for cleansing curly or frizzy hair and the scalp thereof, and a method for cleansing them using said liquid detergent composition.

Abstract: The present invention relates to a product including: i) at least one hair-treatment composition, and ii) at least a first item of information representative of at least one measurable parameter associated with the form of at least one hair from a head of hair for which said composition is suitable and/or from a head of hair likely to be obtained after applying the composition.

Abstract: The present invention relates to individualized porous particles, characterized in that they have a volume-average diameter of less than or equal to 10 ?m and a specific surface area of greater than or equal to 1 m2/g, and in that they comprise at least one cosmetically or pharmaceutically active compound at least present inside said particles.

Abstract: The present invention consists of a cosmetic or dermatological composition comprising, in a physiologically acceptable medium: at least one alkynyl carbamate of formula (I) below:  in which: A denotes a halogen atom R denotes a hydrogen atom, an alkyl group, a hydroxyalkyl group, and at least one polyol chosen from non-etherified polyols, and (poly)alkyl or (poly)alkenyl polyol ethers; these polyols containing from 4 to 28 carbon atoms and from 2 to 6 hydroxyl functions, with the proviso that at least two of these hydroxyl functions are free; uses of these compositions and a cosmetic treatment process using these compositions.

Abstract: The invention concerns the use of an alcohol dehydrogenase enzyme inhibitor in cosmetic treatment of keratinous materials, to prevent, attenuate and/or eliminate undesirable effects of primary alcohols at the surface layers of the skin and its appendages.

Abstract: The invention relates to the use of hydroxystilbenes for dyeing, to ready-to-use dye compositions comprising them, to a dyeing process using them and to a multi-compartment device containing the compositions used in the processes of the invention.

Abstract: The invention relates to the use of hydroxystilbenes for dyeing, to ready-to-use dye compositions comprising them, to a dyeing process using them and to a multi-compartment device containing the compositions used in the processes of the invention.

Abstract: The present invention consists of a cosmetic or dermatological composition comprising, in a physiologically acceptable medium:

Abstract: Dermatological/cosmetic compositions for reducing or decelerating human hair loss comprise an effective hair loss-reducing amount of combinatory immixture of (a) at least one antifungal agent and (b) at least one halogenated antibacterial agent other than a macrolide or pyranoside, characteristically formulated in a topically physiologically acceptable medium therefor.

Abstract: The invention relates to a cosmetic composition comprising a mixture of ceramides, as well as to a process for treating the skin or keratin fibers that comprises applying to the skin or keratin fibers the cosmetic composition.

Abstract: Dermatological/cosmetic compositions for reducing or decelerating human hair loss comprise an effective hair loss-reducing amount of combinatory immixture of (a) at least one antifungal agent and (b) at least one halogenated antibacterial agent other than a macrolide or pyranoside, characteristically formulated in a topically physiologically acceptable medium therefor.

Abstract: Dermatological/cosmetic compositions for reducing or decelerating human hair loss comprise an effective hair loss-reducing amount of combinatory immixture of (a) at least one antifungal agent and (b) at least one halogenated antibacterial agent other than a macrolide or pyranoside, characteristically formulated in a topically physiologically acceptable medium therefor.

Abstract: The invention relates to a composition intended for the treatment of skin aging, containing, in a physiologically acceptable medium, at least one salicylic acid derivative corresponding to the formula: ##STR1## in which: R represents a saturated aliphatic chain or an unsaturated chain bearing one or more conjugated or unconjugated double bonds, it being possible for the chains to be substituted with one or more halogen atoms as well as with trifluoromethyl groups, with one or more hydroxyl groups in free form or a form esterified by an acid, or alternatively with a carboxyl group, free or esterified by a lower alcohol; andR' represents a hydroxyl group or an ester group of formula: ##STR2## where R.sub.1 is a saturated or unsaturated aliphatic group.

Abstract: A method for the differential coloration of skin cells and their nucleii fixed on a transparent or translucent adhesive support, involves successively immersing the cells in two baths, A and B, bath A containing methyl blue or a derivative of methyl blue and bath B containing methyl blue, and/or methylene blue and rhodamine B or a derivative of rhodamine, and then rinsing and drying the support. This method of coloration can be used in the diagnosis of inflammatory skin conditions.

Abstract: This composition contains, by way of main active principle, in a pharmaceutically acceptable carrier, at least one substance belonging to the carotenoid family and chosen, in particular, from the group consisting of .alpha.-carotene, .delta.-carotene, .gamma.-carotene, .beta., .beta.-carotene-4,4'-dione, ethyl 8'-apo-.beta.-caroten-8'-oate, .beta.-apo-8'-carotenal, .psi.,.psi.-carotene, .psi.,.psi.-carotene-16,16'-diol and .psi.,.psi.-caroten-16-ol. This composition preferably contains from 0.001 to 10% by weight of active principle relative to the total weight of the composition and takes the form of a suspension, tablets or gelatin capsules. The pharmacological activity of this drug is an activity which inhibits comedo formation, the latter being due to an irritation caused by an excess of lipid oxide (oxidized squalene).

Abstract: A pharmaceutical or cosmetic composition contains as an active principle a peroxide having an aromatic radical and a saturated group and having the formula ##STR1## wherein R.sub.1 represents linear or branched alkyl having 3 to 17 carbon atoms, substituted or not by one or more halogens, interrupted or not by a carbonyl group and carrying a terminal carboxylic acid group esterified or not or R.sub.1 represents cycloalkyl having 5 to 10 carbon atoms, and R.sub.2 represents hydrogen, halogen, --CF.sub.3, methoxy, ethoxy or acyl having 2 to 16 carbon atoms.The composition is usefully employed in the treatment of various dermatoses including acne.